University of Liverpool

See the following -

Better Use Of Electronic Health Records Makes Clinical Trials Less Expensive

Press Release | University of Manchester | July 11, 2014

Using electronic health records to understand the best available treatment for patients, from a range of possible options, is more efficient and less costly for taxpayers than the existing clinical trial process, a new study shows...

Read More »

Phage Therapy Shown to Kill Drug-Resistant Superbug

Press Release | University of Liverpool | March 13, 2017

Scientists from the University of Liverpool have shown that phage therapy could offer a safe and effective alternative to antibiotics in the treatment of Cystic Fibrosis lung infections. Chronic lung infections caused by the bacterium Pseudomonas aeruginosa are becoming increasingly difficult to treat due to antimicrobial resistance (AMR). With limited alternative therapeutic options available this has led to a renewed interest in (bacterio)phage therapy. Phages are viruses that kill bacteria but are otherwise harmless. A major advantage is that phages only target the harmful bacteria, so there are less side of the effects often associated with antibiotics...

Read More »

Pharmaceutical Giant 'Plotted to Destroy Cancer Drugs to Drive Price Up 4,000%

Katie Forster | Independent | April 15, 2017

Leaked internal emails appear to show employees at one of the world’s leading pharmaceutical companies calling for “celebration” over price hikes of cancer drugs, an investigation has revealed. Staff at Aspen Pharmacare reportedly plotted to destroy stocks of life-saving medicines during a price dispute with the Spanish health service in 2014. After purchasing five different cancer drugs from British firm GlaxoSmithKline (GSK), the company tried to sell the medicines in Europe for up to 40 times their previous price, reported The Times...

Read More »